Human Papillomavirus (HPV)

Recent News

Jun 14, 2018

News Scan for Jun 14, 2018

More suspected DRC Ebola
Salmonella egg outbreak
HPV vaccination messaging
Manure-related E coli illness
May 09, 2018

News Scan for May 09, 2018

More romaine E coli cases
Predicting pandemic severity
Lassa fever cases
HPV vaccine meta-analysis
May 07, 2018

News Scan for May 07, 2018

Largest-ever cholera vaccine drive
Hepatitis A across US
Low HPV vaccine uptake
Mar 23, 2018

News Scan for Mar 23, 2018

Contact precautions and resistance
Antimicrobial use on farms
Polio in Afghanistan
HPV vaccine uptake
Dec 27, 2017

News Scan for Dec 27, 2017

Saudi MERS case
Yellow fever in Nigeria
South Korean anthrax developments
HPV gender breakdown
Oct 18, 2017

News Scan for Oct 18, 2017

No Seychelles plague cases
Influenza B antibody
HPV vaccine safety
Oct 17, 2017
Man's mouth

Study finds high burden of oral HPV, related cancers in men

HPV-related head and neck cancers are dramatically higher in men than in women.

Sep 20, 2017
Cotton swab and test tube

Study: HPV screen bests Pap smear at detecting cervical cancer

The study involved almost 5,000 women in a country with high vaccine uptake.

Sep 06, 2017
HPV vaccination in Brazil

HPV vaccine may protect against 90% of cervical cancers

Researchers report a 97.4% efficacy for the 9-strain HPV vaccine.

Aug 25, 2017
Teen vaccination

CDC: HPV vaccine rates climb, but disparities exist

Though coverage still isn't optimal, for the first time rates topped 60%, with the boys' level gaining ground on the girls'.

Resources & Literature

Recent Literature

Amorim AT, Marques LM, Campos GB, et al. Co-infection of sexually transmitted pathogens and human papillomavirus in cervical samples of women of Brazil. BMC Infect Dis 2017 Dec 15;17:769

Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 2018 (published online May 9)

Artemchuk H, Triglav T, Ostrbenk A, et al. Seroprevalences for 11 human papillomavirus (HPV) types mark cumulative HPV exposure. J Infect Dis 2018 (published online Feb 26)

Aziz H, Iqbal H, Mahmood H, et al. Human papillomavirus (HPV) infection in females with normal cervical cytology: genotyping and phylogenetic analysis among women in Punjab, Pakistan. Int J Infect Dis 2017 (published online Nov 11)

Bodson J, Wilson A, Warner EL, et al. Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah. PLoS One 2017 Aug 25;12(8):e0183725

Boyd ED, Phillips JM, Schoenberger YMM, et al. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine 2018 (published online May 21)

Canfell K, Caruana M, Gebski V, et al. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the Compass pilot randomised trial. PLoS Med 2017 Sep 19;14(9):e1002388

Combes JD, Heard I, Poizot-Martin I, et al. Prevalence and risk factors for anal human papillomavirus infection in HIV-positive men having sex with men. J Infect Dis 2018 (published online Jan 31)

D'Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol 2017 (published online Oct 19)

Dempsey AF, Pyrznawoski J, Lockhart, S, et al. Effect of health care professional communication training intervention on adolescent human papillomavirus vaccination. JAMA Pediatr 2018 (published online Mar 5)

Donken R, King AJ, Bogaards JA, et al. High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females. J Infect Dis 2018 (published online Feb 2)

Eldridge RC, Pawlita M, Wilson L, et al. Smoking and subsequent HPV infection: a mediation analysis. Ann Epidemiol 2017 (published online Oct 17)

Gargano JW, Zhou F, Stokley S, et al. Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States 2007-2014. Vaccine 2018 (published online May 4)

Garland SM, Pitisuttithum P, Ngan HYS, et al. Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine: subgroup analysis of participants from Asian countries. J Infect Dis 2018 (published online May 15)

Gee J, Sukumaran L, Weintraub E, et al. Risk of Guillain-Barre syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink. Vaccine 2017 (published online Sep 19)

Guo F, Cofie LE, Berenson AB. Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction.  Am J Prev Med 2018 (published online May 30)

Habbous S, Chu KP, Lau H, et al. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ 2017 Aug 14;189(32):E1030-40

Hanson KE, Koch B, Bonner K, et al. National trends in parental HPV vaccination intentions and reasons for hesitancy, 2010-2015. Clin Infect Dis 2018 (published online Mar 27)

Huh WK, Joura EA, Giuliano AR, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017 (published online Sep 5)

Hviid A, Svanstrom H, Scheller NM, et al. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med 2017 (published online Oct 18)

Kavanagh K, Pollock KG, Cuschieri K, et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis 2017 (published online Sep 28)

Kjaer SK, Nygard M, Dillner J, et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries. Clin Infect Dis 2017 (published online Oct 1)

Klosky JL, Hudson MM, Chen Y, et al. Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol 2017 (published online Aug 24)

Kojic EM, Conley L, Bush T, et al. Prevalence and incidence of anal and cervical high-risk human papillomavirus (HPV) types covered by current HPV vaccines among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). J Infect Dis 2018 (published online Feb 14)

Konno R, Konishi H, Sauvaget C, et al. Effectiveness of HPV vaccination against high grade cervical lesions in Japan. Vaccine 2018 (published online May 21)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»